Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer
Top Cited Papers
- 1 September 2020
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 33 (9), 1746-1752
- https://doi.org/10.1038/s41379-020-0544-x
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA219647, R01CA219647)
- Breast Cancer Research Foundation (BCRF-19-138)
- U.S. Department of Health & Human Services | NIH | National Cancer Institute
This publication has 14 references indexed in Scilit:
- Immune Marker Profiling and Programmed Death Ligand 1 Expression Across NSCLC MutationsJournal of Thoracic Oncology, 2018
- Immunological differences between primary and metastatic breast cancerAnnals of Oncology, 2018
- PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 ProjectJournal of Thoracic Oncology, 2018
- Abstract PD6-01: Prevalence of PDL1 and tumor infiltrating lymphocytes (TILs) in primary and metastatic TNBCCancer Research, 2018
- Whole Slide Imaging Versus Microscopy for Primary Diagnosis in Surgical PathologyThe American Journal of Surgical Pathology, 2018
- Key factors of people's willingness to pay for green buildings in a less developed region in China: A pilot research effort in Shanxi ProvinceInternational Review for Spatial Planning and Sustainable Development, 2018
- Comparison of immune microenvironments between primary tumors and brain metastases in patients with breast cancerOncotarget, 2017
- A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non–Small Cell Lung CancerJAMA Oncology, 2017
- PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison ProjectJournal of Thoracic Oncology, 2017
- PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomasHuman Pathology, 2015